These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16368870)

  • 1. Advances in the treatment of metastatic colorectal cancer.
    Goldberg RM
    Oncologist; 2005; 10 Suppl 3():40-8. PubMed ID: 16368870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New systemic frontline treatment for metastatic colorectal carcinoma.
    Braun AH; Achterrath W; Wilke H; Vanhoefer U; Harstrick A; Preusser P
    Cancer; 2004 Apr; 100(8):1558-77. PubMed ID: 15073842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic therapy for metastatic colorectal cancer: current options, current evidence.
    Kelly H; Goldberg RM
    J Clin Oncol; 2005 Jul; 23(20):4553-60. PubMed ID: 16002847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C Study.
    Fuchs CS; Marshall J; Mitchell E; Wierzbicki R; Ganju V; Jeffery M; Schulz J; Richards D; Soufi-Mahjoubi R; Wang B; Barrueco J
    J Clin Oncol; 2007 Oct; 25(30):4779-86. PubMed ID: 17947725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in chemotherapy against advanced or metastatic colorectal cancer.
    Omura K
    Digestion; 2008; 77 Suppl 1():13-22. PubMed ID: 18204257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
    Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there a third-line therapy for metastatic colorectal cancer?
    Grothey A
    Semin Oncol; 2006 Dec; 33(6 Suppl 11):S36-8. PubMed ID: 17178284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [IFL].
    Yamazaki K; Yoshino T; Boku N
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):907-10. PubMed ID: 16835478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update on treatment advances for the first-line therapy of metastatic colorectal cancer.
    Lee JJ; Chu E
    Cancer J; 2007; 13(5):276-81. PubMed ID: 17921724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness projections of oxaliplatin and infusional fluorouracil versus irinotecan and bolus fluorouracil in first-line therapy for metastatic colorectal carcinoma.
    Hillner BE; Schrag D; Sargent DJ; Fuchs CS; Goldberg RM
    Cancer; 2005 Nov; 104(9):1871-84. PubMed ID: 16177989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.
    Yoshino T; Boku N; Onozawa Y; Hironaka S; Fukutomi A; Yamaguchi Y; Hasuike N; Yamazaki K; Machida N; Ono H
    Jpn J Clin Oncol; 2007 Sep; 37(9):686-91. PubMed ID: 17720736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [FOLFIRI regimen for metastatic or recurrent colorectal cancer].
    Uemura N; Yamada Y
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):904-6. PubMed ID: 16835477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of UFT in metastatic colorectal cancer.
    Bennouna J; Saunders M; Douillard JY
    Oncology; 2009; 76(5):301-10. PubMed ID: 19299903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Third-line therapy for metastatic colorectal cancer.
    Gundgaard MG; Soerensen JB; Ehrnrooth E
    Cancer Chemother Pharmacol; 2008 Jan; 61(1):1-13. PubMed ID: 17786445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biweekly oxaliplatin plus 1-day infusional fluorouracil/leucovorin followed by metronomic chemotherapy with tegafur/uracil in pretreated metastatic colorectal cancer.
    Lin PC; Chen WS; Chao TC; Yang SH; Tiu CM; Liu JH
    Cancer Chemother Pharmacol; 2007 Aug; 60(3):351-6. PubMed ID: 17111120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bevacizumab: new drug. Metastatic colorectal cancer: good in theory, not in practice.
    Prescrire Int; 2006 Jun; 15(83):94-7. PubMed ID: 16764097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival of patients with advanced colorectal cancer may not be due to the response to chemotherapy.
    Stathopoulos GP; Rigatos SK; Malamos NA; Stathopoulos JG; Thallasinou P; Papazachariou E; Antoniou F; Kondopodis E; Xynotroulas J
    Oncol Rep; 2004 Dec; 12(6):1295-300. PubMed ID: 15547753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of metastatic rectal cancer showing a sustained complete response to chemotherapy with FOLFIRI followed by UFT].
    Tashima R; Yokoyama S; Yamashita Y; Baba K; Matsuda M
    Gan To Kagaku Ryoho; 2007 Oct; 34(10):1663-6. PubMed ID: 17940386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capecitabine chemotherapy for metastatic colorectal cancer. Chemical structure, combinations and efficacy.
    Koukourakis G; Kouloulias V; Zacharias G; Koukourakis M
    J BUON; 2010; 15(4):652-9. PubMed ID: 21229625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid evolution in colorectal cancer: therapy now and over the next five years.
    de Gramont A
    Oncologist; 2005 Oct; 10 Suppl 2():4-8. PubMed ID: 16272453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.